OTC & Nutraceuticals India

India Antimicrobial Alternatives for Livestock Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

India Antimicrobial Alternatives for Livestock Market Industry Trends and Forecast to 2034: Segmented by (Product, Animal, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

India · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $116.6 Mn Placeholder estimate
Estimate 2025 $129.2 Mn 1.8% of the global market
Projected 2034 $325.1 Mn 151.7% Adds $195.9 Mn over 9 forecast years
CAGR 2025–2034 10.8% Faster than 70% of 84 OTC & Nutraceuticals markets here
Key players 5
  • India is 1.85% of the global market.
  • In APAC, the largest is China at $601.6 Mn.
  • Fastest growing: India (this report) at 10.8% a year.
  • India ranks 3rd of 10 by size in APAC.

Market size projection

India

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$195.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Antimicrobial Alternatives for Livestock Market market size by year, India
YearMarket sizeChange that yearSince 2025
2024 (estimate) $116.6 Mn — —
2025 (base) $129.2 Mn +$12.6 Mn —
2026 (forecast) $143.1 Mn +$13.9 Mn +10.8%
2027 (forecast) $158.6 Mn +$15.5 Mn +22.8%
2028 (forecast) $175.7 Mn +$17.1 Mn +36%
2029 (forecast) $194.6 Mn +$19.0 Mn +50.7%
2030 (forecast) $215.7 Mn +$21.0 Mn +67%
2031 (forecast) $239.0 Mn +$23.3 Mn +85%
2032 (forecast) $264.8 Mn +$25.8 Mn +105%
2033 (forecast) $293.4 Mn +$28.6 Mn +127.2%
2034 (forecast) $325.1 Mn +$31.7 Mn +151.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

India Antimicrobial Alternatives for Livestock Market Analysis at a glance
Market size, 2025$129.2 Mn placeholder estimate
Forecast, 2034$325.1 Mn placeholder estimate
Growth (CAGR), 2025–203410.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct and animal (see all)
Key playersDSM-Firmenich, Novonesis, Cargill, Inc, Elanco, Phibro Animal Health (see all)
Regulator in IndiaCDSCO and FSSAISource: Central Drugs Standard Control Organisation. Checked 14 Nov 2026.Source: Food Safety and Standards Authority of India. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The India Antimicrobial Alternatives for Livestock Market Analysis Executive Summary

Antimicrobial alternatives for livestock replace antibiotics in farming with probiotics, enzymes, vaccines and plant extracts.

Key segments of the antimicrobial Alternatives for Livestock market include product (Probiotics, Prebiotics and Phytogenics) and animal (Poultry, Swine and Cattle).

Bar chart: India Antimicrobial Alternatives for Livestock market size, 2024–2034, placeholder estimates. $116.6 Mn in 2024, $129.2 Mn in 2025 and $325.1 Mn in 2034, 10.8% CAGR.
India Antimicrobial Alternatives for Livestock market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

India Antimicrobial Alternatives for Livestock Market Dynamics

Market Growth Drivers

More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the antimicrobial Alternatives for Livestock market.

Opportunity

Pet insurance, diagnostics and vaccines for emerging animal diseases give the antimicrobial Alternatives for Livestock market room to grow.

Market Restraints

Cost-sensitive farmers, fewer vets in rural areas, rules on antibiotic use in animals and slow approvals hold back the antimicrobial Alternatives for Livestock market.

Competitive Landscape for Antimicrobial Alternatives for Livestock Market in India

The antimicrobial Alternatives for Livestock market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Antimicrobial Alternatives for Livestock Market in India

Antimicrobial Alternatives for Livestock in India: rules

New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India.⁠[1] Health supplements and nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI).⁠[2]

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern antimicrobial Alternatives for Livestock products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in India.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Antimicrobial Alternatives for Livestock right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Antimicrobial Alternatives for Livestock in context

India compared

  • Health spending per person: 85 US$ per person (2023). World: 1,317 US$ per person (2023). 12th highest of the 17 countries we cover in APAC.[1]
  • Doctors: 0.72 per 1,000 people (2020). World: 1.86 per 1,000 people (2022). 13th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 7.4% of people (2025). World: 10.4% of people (2025). 13th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 22 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 22 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Antimicrobial Alternatives for Livestock market in India?
Placeholder estimate: about $129.2 Mn in 2025, rising to about $325.1 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Antimicrobial Alternatives for Livestock market in India growing?
Placeholder estimate: about 10.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Antimicrobial Alternatives for Livestock market report cover?
The report splits the market by product (Probiotics, Prebiotics, Phytogenics, Enzymes and more) and animal (Poultry, Swine, Cattle, Aquaculture).
Who are the key players in the Antimicrobial Alternatives for Livestock market?
Key players include DSM-Firmenich, Novonesis, Cargill, Inc, Elanco and Phibro Animal Health.
What is driving the Antimicrobial Alternatives for Livestock market?
More pets per household, owners treating pets as family, livestock disease risks and the One Health approach linking animal and human health are driving the antimicrobial Alternatives for Livestock market.
Who regulates Antimicrobial Alternatives for Livestock in India?
New drugs and clinical trials need approval from the Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India. Health supplements and nutraceuticals are regulated by the Food Safety and Standards Authority of India (FSSAI). Source: Central Drugs Standard Control Organisation. Checked 14 Nov 2026. Source: Food Safety and Standards Authority of India. Checked 14 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in India

See all

Related on animal health and antibiotics

See the topic